Scandinavian countries suspend the use of Moderna's COVID-19 vaccine for young people due to an increased risk of side effects. The decision is based on an unpublished study highlighting potential inflammation of the heart muscle or pericardium. This raises questions about the risk-benefit ratio for vaccinating the young against COVID-19.
